Oncology
Cancer clinical trials
Studies of cancers and tumors of every type and site, from prevention to treatment. We’re tracking 20,277 recruiting studies in this area right now.
By phase
- Not applicable9,578
- Phase 24,420
- Phase 12,682
- Phase 1/Phase 21,651
- Phase 31,397
- Phase 2/Phase 3282
- Phase 4267
Top conditions
- Breast Cancer1,205
- Prostate Cancer647
- Cancer637
- Colorectal Cancer481
- Lung Cancer420
- Ovarian Cancer342
- Multiple Myeloma331
- Pancreatic Cancer289
- Gastric Cancer285
- Acute Myeloid Leukemia279
- Hepatocellular Carcinoma256
- Solid Tumor246
- Advanced Solid Tumor233
- Head and Neck Cancer228
- Cervical Cancer224
- Endometrial Cancer213
- Advanced Solid Tumors206
- Esophageal Cancer191
Leading sponsors
- M.D. Anderson Cancer Center452
- Fudan University305
- National Cancer Institute (NCI)294
- Memorial Sloan Kettering Cancer Center290
- Sun Yat-sen University275
- Mayo Clinic239
- City of Hope Medical Center148
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences145
- AstraZeneca133
- Ruijin Hospital127
Where studies are running
- California1,413
- Texas630
- Arizona510
- Florida434
- Alabama428
- New York407
- Massachusetts340
- Maryland332
- New Jersey275
- Pennsylvania235
Recruiting studies20,277 total
- NCT06766916RecruitingPhase 2
Testing Crisugabalin for nerve pain after radiation
This trial tests a drug called Crisugabalin to see if it helps people with nerve pain caused by radiation treatment for head and neck cancer. The study aims to find a better way to manage this type of pain that does not go away.
Fuzhou, FujianAges 18 years+ - NCT06978829RecruitingPhase 2
Combination therapy for untreated advanced head and neck cancer
This trial tests a combination of three drugs (cetuximab, tislelizumab, and chemotherapy) in people with advanced head and neck cancer that hasn't been treated before. The goal is to see if this mix can shrink tumors and improve outcomes.
Chongqing, Chongqing MunicipalityAges 18 years+ - NCT06977893RecruitingPhase 3
Chemo and immunotherapy for HR+ breast cancer before surgery
This trial tests whether adding the immunotherapy drug toripalimab to chemotherapy before surgery helps women with a certain type of breast cancer (HR+, HER2-). It aims to see if this combination works better than chemotherapy alone.
HangzhouAges 18–75 - NCT06977906Recruiting
Bladder suspension in robotic prostate surgery for advanced cancer
This trial tests a new surgical technique (bladder suspension) during robotic prostate removal for men with locally advanced prostate cancer. It aims to see if this approach improves early recovery and outcomes.
Fuzhou, FujianAges Any age - NCT06972641RecruitingPhase 2/Phase 3
Gene-based maintenance therapy after stem cell transplant
This trial tests different maintenance therapies based on the specific gene mutations in your leukemia or MDS after a stem cell transplant. Your doctor will choose the right drug for your mutation type to help keep the cancer from coming back.
Shanghai, Shanghai MunicipalityAges 14–75 - NCT06978400RecruitingPhase 2
Targeted therapy plus chemo for BRAF mutant colorectal cancer
This trial tests a combination of targeted therapy (dabrafenib) and two other drugs (cetuximab or panitumumab) plus standard chemotherapy (FOLFOX) as a first treatment for people with a specific type of metastatic colorectal cancer that has a BRAF V600E mutation and is microsatellite stable.
MoscowAges 18 years+ - NCT04735198Recruiting
Preventive gallbladder removal for midgut neuroendocrine tumors
This trial looks at whether removing the gallbladder before it causes problems can be helpful for people with midgut neuroendocrine tumors who are already planning primary tumor surgery. It may reduce future gallbladder-related complications around the time of cancer treatment.
Badalona, BarcelonaAges 18 years+ - NCT05491434Recruiting
Study of muscle loss in colon cancer patients
This trial looks at muscle loss (called sarcopenia) in people with colon cancer to test an intervention that may help strength or recovery. If you’re age 70 or older and meet the cancer and health requirements, you may be able to take part.
L'Hospitalet de Llobregat, BarcelonaAges 70 years+ - NCT06947642Recruiting
Comparing numbing blocks for breast surgery
This study compares three ways of numbing the chest muscle and rib area with ultrasound during breast surgery to see which one works best for pain control. If you are having breast surgery and want to help improve pain management, this might be a good fit.
Tanta, El-GharbiaAges 21–65 - NCT05759793RecruitingPhase 1
CAR T trial for relapsed myeloma targeting GPRC5D
This Phase 1 trial tests a CAR T-cell treatment made to find a specific marker called GPRC5D on myeloma (or plasma cell leukemia) cells. It may help people whose disease has returned or hasn’t responded to several prior treatments.
ShanghaiAges 18–75 - NCT05915442RecruitingPhase 2
Adenosine blocker plus immunotherapy for limited prostate spread
This Phase 2 study tests a medicine that affects “adenosine” signaling along with an immune checkpoint inhibitor (immunotherapy) in men with hormone-sensitive prostate cancer that has spread in only a small, limited way. It aims to stop or slow that limited spread by helping the immune system work better.
New York, New YorkAges 18–99 - NCT06254859Recruiting
Nerve monitoring during thyroid surgery and voice outcomes
This study tests whether using nerve monitoring during thyroid surgery helps protect the nerves that control your voice. It includes adults having one side of their thyroid removed and tracks voice changes before and after surgery.
Fuzhou, FujianAges Any age - NCT06367088RecruitingPhase 2
Combination drug therapy for advanced triple-negative breast cancer
This trial tests a new drug (cadonilimab) plus chemotherapy for people with advanced triple-negative breast cancer that has come back or spread. It aims to see if the combination works better than standard treatment.
Wuhan, HubeiAges 18–70 - NCT06809517RecruitingPhase 1/Phase 2
Study of a new antibody plus chemotherapy for leptomeningeal metastasis
This trial tests a combination treatment for cancer that has spread to the lining of the brain and spinal cord (leptomeningeal metastasis). It uses an antibody given directly into the spinal fluid along with a chemotherapy drug, with the goal of targeting the cancer more effectively.
Huizhou, GuangdongAges 21–75 - NCT06979908RecruitingPhase 2
A study of fruquintinib plus immunotherapy for advanced colorectal cancer
This trial tests a combination of three drugs (fruquintinib, a PD-1 inhibitor, and chidamide) for people with a specific type of advanced colorectal cancer that has not responded to at least two prior treatments. The goal is to see if this new combination can shrink tumors or slow the cancer's growth.
Changchun, JilinAges 18–75 - NCT06980155RecruitingEarly Phase 1
Personalized vaccine with or without toripalimab to prevent AML relapse
This trial tests a personalized cancer vaccine, alone or with an immunotherapy drug called toripalimab, to help keep acute myeloid leukemia (AML) in remission. It is for people who have finished initial treatment, are in remission, but still have some leukemia cells remaining (MRD positive) and have a specific NPM1 gene mutation.
ShanghaiAges 18 years+ - NCT06980740Recruiting
Video tumor board for skin cancer patients
This trial tests a video-based tumor board where doctors discuss difficult skin cancer cases. It aims to help patients who are being treated outside the main cancer center get expert advice.
BonnAges 18 years+ - NCT06980532RecruitingPhase 1/Phase 2
Glumetinib and Fruquintinib for advanced colorectal cancer
This trial tests a combination of two targeted drugs (Glumetinib and Fruquintinib) for people with a specific type of advanced colorectal cancer that has a change in the MET gene (amplification) or too much MET protein. It is for those whose cancer has not responded to at least two prior treatments.
Wuhan, HubeiAges 18 years+ - NCT06981377Recruiting
Prostate cancer blood test research study
This study is looking at blood samples from people with prostate cancer to better understand the disease. It may help researchers find new ways to monitor or treat prostate cancer.
Meldola, Forlì-CesenaAges 18 years+ - NCT06981455Recruiting
Life after surgery for neuroendocrine tumors
This study follows people after surgery to remove neuroendocrine tumors (NETs) from the stomach, intestines, or pancreas. It aims to understand long-term outcomes and quality of life.
Toronto, OntarioAges 18 years+ - NCT04295473Recruiting
Test of smaller-incision stomach surgery for gastric cancer
This trial studies a stomach cancer surgery done with fewer/smaller incisions (laparoscopic with reduced ports). It may help people with certain early-to-mid stage stomach cancers by comparing whether this approach is safe and effective for them.
Nanchong, SichuanAges 18–90 - NCT03117036Recruiting
Study follows people with Hodgkin or non-Hodgkin lymphoma
This study enrolls adults with Hodgkin or non-Hodgkin lymphoma who plan to receive chemotherapy aimed at cure. It may help doctors better understand outcomes and how lymphoma care is managed over time.
SeoulAges 20–90 - NCT05439278RecruitingPhase 3
Radiation schedules plus temozolomide for elderly glioblastoma
This study compares a standard radiation schedule versus a shorter, higher-dose radiation schedule, both with the chemotherapy medicine temozolomide, in older adults with newly diagnosed glioblastoma. It aims to see which approach works better and is practical for people age 70 and older.
SeoulAges 70 years+ - NCT06915857RecruitingPhase 3
Betamethasone cream vs moisturizer for radiation rash in large-breasted women
This trial tests whether a betamethasone steroid cream works better than regular moisturizer to prevent skin reactions from radiation therapy. It is for women with large breasts who are getting radiation lying face down after breast-conserving surgery.
Toronto, OntarioAges 18 years+
Common questions
- How many cancer clinical trials are recruiting?
- Clin2 is tracking 20,277 recruiting oncology studies from the U.S. registry right now, out of 30,919 we cover in this area in total.
- What does “Cancer” cover here?
- Studies of cancers and tumors of every type and site, from prevention to treatment. We group each study into cancer based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a cancer trial near me?
- Use the search to filter cancer studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.